This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yao, K. Articles by O'Dwyer, P. J. Search for Related Content PubMed PubMed Citation Articles by Yao, K. Articles by O'Dwyer, P. J.

Macrophage Migration Inhibitory Factor Is a Determinant of Hypoxia-Induced Apoptosis in Colon Cancer Cell Lines

Authors' Affiliations: ¹ University of Pennsylvania and ² Fox Chase Cancer Center, Philadelphia, Philadelphia

Requests for reprints: Peter J. O'Dwyer, University of Pennsylvania, 51 North 39th Street, MAB Suite 103, Philadelphia, PA 19104. Phone: 215-662-8636; Fax: 215-243-3269; E-mail: peter.odwyer{at}uphs.upenn.edu.

Hypoxia contributes to cytotoxic chemotherapy and radiation resistance and may play a role in the efficacy of antiangiogenesis cancer therapy. We have generated a series of cell lines derived from the colon adenocarcinoma models HT29 and HCT116 by exposing cells in vitro to repeated sublethal periods of profound hypoxia. These cell lines have altered sensitivity to hypoxia-induced apoptosis: those derived from HT29 are resistant, whereas those from HCT116 are more susceptible. We used cDNA selected subtractive hybridization to identify novel genes mediating sensitivity to hypoxia-induced apoptosis and isolated macrophage migration inhibitory factor (MIF) from the hypoxia-conditioned cell lines. MIF expression correlates with susceptibility of the cell lines to apoptosis. In hypoxia-resistant cells, the induction of apoptosis by hypoxia can be restored by the addition of exogenous recombinant MIF protein, suggesting that resistance may result in part from down-regulation of MIF production possibly through an autocrine loop. Inhibition of MIF using small interfering RNA in the susceptible lines conferred resistance to hypoxia-induced cell death. The relative expression of MIF in the hypoxia-conditioned cells implanted s.c. in severe combined immunodeficient mice in vivo was similar to that observed in vitro. In an analysis of 12 unrelated colon tumor cell lines, MIF expression and response to hypoxia varied widely. Cell lines in which MIF was inducible by hypoxia were more sensitive to oxaliplatin. In human colon tumor specimens analyzed by immunohistochemistry, MIF expression was similarly variable. There was no detectable expression of MIF in normal colon mucosa or adenoma but positive staining in all carcinomas tested. Taken together, these data indicate that MIF may be a determinant of hypoxia-induced apoptosis in vitro and that its variable expression in human colon cancers may indicate a functional role in vivo. We suggest that MIF expression in colorectal cancer may be a marker of susceptibility to therapies that may depend on induction of hypoxia, possibly including antiangiogenic therapy.

This article has been cited by other articles:

				A. L. Man, F. Lodi, E. Bertelli, M. Regoli, C. Pin, F. Mulholland, A. R. Satoskar, M. J. Taussig, and C. Nicoletti Macrophage Migration Inhibitory Factor Plays a Role in the Regulation of Microfold (M) Cell-Mediated Transport in the Gut J. Immunol., October 15, 2008; 181(8): 5673 - 5680. [Abstract] [Full Text] [PDF]

				H. Jung, H.-A Seong, and H. Ha Critical Role of Cysteine Residue 81 of Macrophage Migration Inhibitory Factor (MIF) in MIF-induced Inhibition of p53 Activity J. Biol. Chem., July 18, 2008; 283(29): 20383 - 20396. [Abstract] [Full Text] [PDF]

				I. A. Vasilevskaya, M. Selvakumaran, and P. J. O'Dwyer Disruption of Signaling through SEK1 and MKK7 Yields Differential Responses in Hypoxic Colon Cancer Cells Treated with Oxaliplatin Mol. Pharmacol., July 1, 2008; 74(1): 246 - 254. [Abstract] [Full Text] [PDF]

				Y.-C. Hsieh, M. Frink, C.-H. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1227 - L1232. [Abstract] [Full Text] [PDF]

				H.-A Seong, H. Jung, and H. Ha NM23-H1 Tumor Suppressor Physically Interacts with Serine-Threonine Kinase Receptor-associated Protein, a Transforming Growth Factor-beta (TGF-beta) Receptor-interacting Protein, and Negatively Regulates TGF-beta Signaling J. Biol. Chem., April 20, 2007; 282(16): 12075 - 12096. [Abstract] [Full Text] [PDF]

				H.-A Seong, H. Jung, K.-T. Kim, and H. Ha 3-Phosphoinositide-dependent PDK1 Negatively Regulates Transforming Growth Factor-beta-induced Signaling in a Kinase-dependent Manner through Physical Interaction with Smad Proteins J. Biol. Chem., April 20, 2007; 282(16): 12272 - 12289. [Abstract] [Full Text] [PDF]

				A. Maity and C. Koumenis HIF and MIF--a nifty way to delay senescence? Genes & Dev., December 15, 2006; 20(24): 3337 - 3341. [Full Text] [PDF]

				C. A. Learn, P. E. Fecci, R. J. Schmittling, W. Xie, I. Karikari, D. A. Mitchell, G. E. Archer, Z. Wei, H. Dressman, and J. H. Sampson Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers Clin. Cancer Res., December 15, 2006; 12(24): 7306 - 7315. [Abstract] [Full Text] [PDF]

				P. J. O'Dwyer The Present and Future of Angiogenesis-Directed Treatments of Colorectal Cancer Oncologist, October 1, 2006; 11(9): 992 - 998. [Abstract] [Full Text] [PDF]